scispace - formally typeset
G

Geoffrey Dusheiko

Researcher at University College London

Publications -  98
Citations -  5737

Geoffrey Dusheiko is an academic researcher from University College London. The author has contributed to research in topics: Hepatitis B & Hepatitis B virus. The author has an hindex of 31, co-authored 98 publications receiving 4765 citations. Previous affiliations of Geoffrey Dusheiko include University of Cambridge & Royal Free London NHS Foundation Trust.

Papers
More filters
Journal ArticleDOI

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.

TL;DR: In patients with chronic hepatitis C and cirrhosis or bridging fibrosis, 180 microg of peginterferon alfa-2a administered once weekly is significantly more effective than 3 million units of standard interferonAlfa- 2a administered three times weekly.
Journal ArticleDOI

Hepatitis B virus infection

TL;DR: This Primer addresses several aspects of HBV infection, including epidemiology, immune pathophysiology, diagnosis, prevention and management, including antiviral agents that directly act on viral replication and immunomodulators, such as interferon therapy.
Journal ArticleDOI

Hepatitis B cure: From discovery to regulatory approval

TL;DR: Development of standardised assays for novel biomarkers toward better defining hepatitis B virus cure should occur in parallel with development of novel antiviral and immune modulatory therapies such that approval of new treatments can be linked to the approval ofnew diagnostic assays used to measure efficacy or to predict response.
Journal ArticleDOI

Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.

TL;DR: Both Tim-3 and galectin-9 are increased in CHB and may contribute to the inhibition and deletion of T cells as they infiltrate the HBV-infected liver.